Stevia Nutra Corp (STNT) 0.0016 $STNT STENTYS Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Stevia Nutra Corp (STNT) 0.0016 $STNT

STENTYS Announces CE Marking of Its Longest Xposition Stent
BusinessWire - Wed Jun 08, 10:46AM CDT
Regulatory News:

STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease
BusinessWire - Mon Mar 21, 1:00AM CDT
Regulatory News:

STENTYS Successfully Completes EUR12.6 Million Capital Increase
BusinessWire - Fri Mar 04, 11:59AM CST
Regulatory News:

STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues
BusinessWire - Wed Jan 13, 10:45AM CST
Regulatory News:

STENTYS: Enrollment Completion of MiStent Randomized Trial against Xience
BusinessWire - Wed Dec 09, 10:45AM CST
--Primary endpoint results to be announced in H1 2017

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years
BusinessWire - Mon Oct 12, 12:09PM CDT
STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) coronary stent, today announces that three-year follow-up imaging data from the STENTYS arm of the APPOSITION IV clinical study confirms the long-term performance of the sirolimus-eluting Self-Apposing stent. The data will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco, CA.

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease
BusinessWire - Mon Sep 28, 11:07AM CDT
STENTYS (Paris:STNT)(FR0010949404 -- STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) coronary stent, today announced that the Company's Drug-Eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries, making STENTYS' product the first self-expanding and drug-eluting stent with regulatory approval in Europe for this indication.

STENTYS Reports First Half 2015 Financial Results
BusinessWire - Thu Sep 17, 11:57AM CDT
--Gross margin up 1,400 basis points to 53%

STENTYS Reports 40% Increase in Revenues in Second Quarter of 2015
BusinessWire - Wed Jul 08, 11:16AM CDT
STENTYS (Paris:STNT) (FR0010949404 - STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) coronary stent, today announces its revenues and cash position at June 30, 2015.

STENTYS Reports First Quarter 2015 Revenues Rose 28%
BusinessWire - Thu Apr 16, 11:14AM CDT
STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) coronary stent, today announces revenues for the first quarter of 2015.

STENTYS 2014 Annual Results
BusinessWire - Tue Mar 31, 12:22PM CDT
--Solid cash position of EUR18.6 million allowing the commercial launch of the new product portfolio

STENTYS Expands Benefits of First Drug-Eluting, Self-Expanding Stent to Lower Limb Artery Disease
BusinessWire - Wed Jan 28, 11:25AM CST
STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) coronary stent, today announced that its unique Drug-Eluting and Self-Expanding stent was evaluated in 70 patients suffering from critical limb ischemia (CLI) and prevented foot amputation in 99% of them.

STENTYS' Sirolimus-Eluting Stent Receives CE Marking
BusinessWire - Mon Oct 27, 12:50PM CDT
Regulatory News:

STENTYS Revenues for the First 9 Months of 2014 up 16.9%
BusinessWire - Thu Oct 23, 10:45AM CDT
STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing, in Europe, the world's first and only Self-Apposing(R) stent to treat acute myocardial infarction (AMI), today announces revenues for the third-quarter and nine-months ended September 30, 2014.

STENTYS Wins Large Regional Tender in Middle East
BusinessWire - Mon Oct 20, 12:17PM CDT
Regulatory News:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 4

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 5

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Interpublic Board Approves Quarterly Dividend Payment Announcement

Updated Category News Views 147

Interpublic Board Declares Quarterly Dividend Interpublic Group (NYSE: IPG), a major player in the marketing solutions landscape, has made a significant announcement regarding its common stock. The company's Board of Directors has officially declared a quarterly dividend of $0.33 per share on its common stock. This decision marks a continued commitment to providing value...

Continue Reading
Free Heart and Kidney Health Screenings Set for January in Seattle

Updated Category News Views 268

Free Heart and Kidney Health Screenings in Seattle Residents of Seattle have a valuable opportunity coming up with the Heart & Kidney Health Screening initiative offered by Care Access. This program aims to enhance awareness of crucial health risk factors, particularly the dangerous lipoprotein(a), often abbreviated as Lp(a). Affecting one in five individuals, high Lp(a)...

Continue Reading
Petrus Resources Shares Success of Annual Meeting Outcomes

Updated Category News Views 182

Petrus Resources Shareholders Approve Key Resolutions Petrus Resources Ltd. ('Petrus' or the 'Company') (TSX: PRQ) has great news to share following its recent annual general meeting. The Company, which operates within the oil and gas sector, recently conducted a meeting where shareholders gave their stamp of approval on all presented resolutions. Details of the Meeting...

Continue Reading
Real America's Voice Expands Accessibility on Prime Video

Updated Category News Views 277

Real America's Voice Launches on Prime Video Real America's Voice has exciting news for its viewers. The popular FAST news channel is making its debut on Prime Video, allowing fans to enjoy a wide array of programming from the comfort of their homes. This move marks a significant step in enhancing accessibility for audiences interested in live news, politics, and culture....

Continue Reading
Fortuna Mining Shares Q3 2024 Gold Production Insights

Updated Category News Views 162

Fortuna Mining's Third Quarter Production Overview Fortuna Mining Corp. released its production figures for the third quarter of 2024, highlighting solid outputs from its diversified mining operations. With gold equivalent production recorded at 110,820 ounces, the company continues to maintain its robust performance across its five operational mines in various regions....

Continue Reading